inxmed limited
PrivateLast Round
Series C
Aug 22, 2025
Last Round Size
$34M
Est. Valuation
$306M
Total Funding Raised
$134M
Company Overview
Developer of cancer therapeutics targeting drug resistance and the stroma microenvironment for hard-to-treat solid tumors.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inxmed limited Comps
Related companies by embedding similarity.
inxmed limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 22, 2025 | ||||
| Series B Extension | May 8, 2022 | ||||
| Series B | Mar 3, 2022 | ||||
| Series A Extension | Sep 3, 2020 | ||||
| Series A | Dec 31, 2018 |
inxmed limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about inxmed limited's valuation, stock price, and market status.